Frequency of platelet type versus type 2B von Willebrand disease: An international registry-based study

Thrombosis and Haemostasis

Volumn 105, Issue 3, 2011, Pages 501-508

  Hamilton, Alexander ^a   Ozelo, Margareth ^b   Leggo, Jayne ^c   Notley, Colleen ^c   Brown, Hannah ^c   Frontroth, Juan Pablo ^d   Angelillo Scherrer, Anne ^e   Baghaei, Fariba ^f   Enayat, Said M ^g   Favaloro, Emmanuel ^h   Lillicrap, David ^c   Othman, Maha ^a,c  

^a LAURENTIAN UNIVERSITY   (Canada)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c QUEEN S UNIVERSITY   (Canada)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^h WESTMEAD HOSPITAL   (Australia)

Author keywords

GP1BA, rare bleeding disorders; Platelet function defect; Platelets; RIPA; Type 2B VWD; VWF multimers; VWF A1 domain

Indexed keywords

DNA; VON WILLEBRAND FACTOR;

ARTICLE; DIAGNOSTIC ERROR; DNA DETERMINATION; EXON; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GP1BA GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PLATELET TYPE VON WILLEBRAND DISEASE; PRIORITY JOURNAL; REGISTER; VON WILLEBRAND DISEASE; VWF GENE;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; DNA; EXONS; FEMALE; HEMOSTASIS; HUMANS; INTERNATIONAL COOPERATION; MALE; MEMBRANE GLYCOPROTEINS; MUTATION; PLATELET COUNT; REGISTRIES; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND FACTOR;

EID: 79952525129     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0523     Document Type: Article

References (43)

1. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-777. (Pubitemid 41647892)
2. Titani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-3184. (Pubitemid 16056960)
3. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-19527. (Pubitemid 20008053)
4. Federici AB, Mannucci PM, Stabile F, et al. A type 2b von Willebrand disease mutation (Ile546 ->Val) associated with an unusual phenotype. Thromb Haemost 1997; 78: 1132-1137. (Pubitemid 27417313)
5. Casonato A, Sartorello F, Pontara E, et al. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. Thromb Haemost 2007; 98: 1182-1187. (Pubitemid 350239088)
6. Baronciani L, Federici AB, Beretta M, et al. Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding. J Thromb Haemost 2005; 3: 2689-2694. (Pubitemid 41819797)
7. Takimoto Y, Imanaka F. Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma. Int J Hematol 1999; 70: 127-131.
8. Poon MC, Rand ML, Jackson SC. 2B or not to be - The 45-year saga of the Montreal Platelet Syndrome. Thromb Haemost 2010; 104; 903-910.
9. Weiss HJ, Meyer D, Rabinowitz R, et al. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 30: 326-333. (Pubitemid 12169113)
10. Miller JL, Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 1982; 60: 790-794. (Pubitemid 12027162)
11. Miller JL. Platelet-type von Willebrand disease. Thromb Haemost 1996; 75: 865-869. (Pubitemid 26355338)
12. Favaloro EJ, Bonar R, Meiring M, et al. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD. Thromb Haemost 2007; 98: 346-358. (Pubitemid 47250238)
13. Whalley IN, Perry DJ. 2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease. Br J Haematol 2007; 136: 345; author reply -346.
14. Othman M, Lillicrap D. Distinguishing between non-identical twins: platelet type and type 2B von Willebrand disease. Br J Haematol 2007; 138: 665-666. (Pubitemid 47206714)
15. Enayat MS, Guilliatt AM, Lester W, et al. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance. Br J Haematol 2006; 133: 664-666. (Pubitemid 43742784)
16. Mathew P, Greist A, Maahs JA, et al. Type 2B vWD: the varied clinical manifestations in two kindreds. Haemophilia 2003; 9: 137-144. (Pubitemid 36511648)
17. Saba HI, Saba SR, Dent J, et al. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation. Blood 1985; 66: 282-286. (Pubitemid 15007012)
18. Olson JD, Preston FE, Nichols WL. External quality assurance in thrombosis and hemostasis: an international perspective. Semin Thromb Hemost 2007; 33: 220-225. (Pubitemid 46581375)
19. Othman M LJ, Notley C, James P, et al. Platelet Type von Willebrand disease: an under diagnosed cause of excessive mucocutanous bleeding. J Thromb Haemost 2007; 5 (Suppl. 1): Abstract P-W-167.
20. Othman M, Ozelo M, Brown H, et al. Canadian Platelet-type von Willebrand disease (PT-VWD) project: Progress and update. J Thromb Haemost 2009; 7 (Suppl. 2): Abstract OC-WE-134.
21. Othman M, Hamilton A. Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project. Acta Haematol 2010; 123: 126-128.
22. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007; 109: 145-154. (Pubitemid 46053055)
23. Othman M, Notley C, Lavender FL, et al. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood 2005; 105: 4330-4336. (Pubitemid 40720779)
24. Favaloro EJ. 2B or not 2B? Differential identification of type 2B, versus pseudovon Willebrand disease. Br J Haematol 2006; 135: 141-142; author reply -143.
25. Favaloro EJ. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Semin Thromb Hemost 2008; 34: 113-127.
26. Frontroth JP, Hepner M, Sciuccati G, et al. Prospective study of low-dose ristocetin- induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children. Thromb Haemost 2010; 104: 1158-1165.
27. Favaloro EJ, Patterson D, Denholm A, et al. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol 2007; 139: 623-626. (Pubitemid 350043816)
28. Scepansky E, Othman M, Smith H. Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas. J Thromb Haemost 2009; 5 (Suppl. 1): Abstract PP-MO-632.
29. Chegeni R, Vickars L, Favaloro EJ, et al. Functional analysis of three recombinant A1 -VWF domain mutants in comparison to wild type and plasma- derived VWF facilitates subtyping in type 2 von Willebrand disease. Thromb Res 2010; published online.
30. Othman M. Differential identification of PT-VWD from type 2B VWD and GP1BA nomenclature issues. Br J Haematol 2008; 142: 312-314; author reply 314-315.
31. Facey DA, Favaloro EJ, Maxwell E, et al. Type 2B von Willebrand's disease in thirteen individuals from five unrelated Australian families: phenotype and genotype correlations. Am J Hematol 2000; 63: 197-199. (Pubitemid 30165406)
32. Favaloro EJ, Koutts J, Brighton T, et al. Genetic testing for the diagnosis of von Willebrand Disease: benefits and limitations. J Coagul Dis 2010; 2: 37-47.
33. Corrales I, Ramirez L, Altisent C, et al. Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene. Thromb Haemost 2009; 101: 570-576.
34. James P, Lillicrap D. The role of molecular genetics in diagnosing von Willebrand disease. Semin Thromb Hemost 2008; 34: 502-508.
35. Othman M, Favaloro EJ. Genetics of type 2B von Willebrand disease: "true 2B", "tricky 2B", or "not 2B". What are the modifiers of the phenotype? Semin Thromb Hemost 2008; 34: 520-531.
36. Federici AB, Mannucci PM, Castaman G, et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 2009; 113: 526-534.
37. Lopez-Fernandez MF, Lopez-Berges C, Martin-Bernal JA, et al. Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy. Am J Hematol 1988; 27: 291-298.
38. Nurden P, Debili N, Vainchenker W, et al. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 2006; 108: 2587-2595.
39. Nurden P, Chretien F, Poujol C, et al. Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease. Br J Haematol 2000; 110: 704-714.
40. Nurden AT, Federici AB, Nurden P. Altered megakaryocytopoiesis in von Willebrand type 2B disease. J Thromb Haemost 2009; 7 (Suppl 1): 277-281.
41. Nurden P, Gobbi G, Nurden A, et al. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood 2010; 115: 2649-2656.
42. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia 1999; 5: 313-317. (Pubitemid 29495707)
43. Novelli EM, Ragni MV. Genetics of bleeding disorders in women. Semin Thromb Hemost 2008; 34: 509-519.